Your browser doesn't support javascript.
loading
Is Timing of Steroid Exposure Prior to Immune Checkpoint Inhibitor Initiation Associated with Treatment Outcomes in Melanoma? A Population-Based Study.
Nikita, Nikita; Banks, Joshua; Keith, Scott W; Song, Andrew; Johnson, Jennifer M; Wilson, Melissa; Sharma, Swapnil; Lu-Yao, Grace.
Affiliation
  • Nikita N; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Banks J; Department of Medical Oncology, Sidney Kimmel Cancer Center (SKCC) at Jefferson, Philadelphia, PA 19107, USA.
  • Keith SW; Department of Pharmacology & Experimental Therapeutics, Division of Biostatistics, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Song A; Department of Pharmacology & Experimental Therapeutics, Division of Biostatistics, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Johnson JM; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Wilson M; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
  • Sharma S; Department of Medical Oncology, Sidney Kimmel Cancer Center (SKCC) at Jefferson, Philadelphia, PA 19107, USA.
  • Lu-Yao G; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Cancers (Basel) ; 14(5)2022 Mar 02.
Article in En | MEDLINE | ID: mdl-35267602
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Risk_factors_studies Language: En Journal: Cancers (Basel) Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza